Unichem Laboratories surges on getting ANDA's approval for Atenolol, Chlorthalidone Tablets

01 Dec 2020 Evaluate

Unichem Laboratories is currently trading at Rs. 264.45, up by 8.95 points or 3.50% from its previous closing of Rs. 255.50 on the BSE.

The scrip opened at Rs. 262.00 and has touched a high and low of Rs. 267.65 and Rs. 262.00 respectively.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 304.20 on 04-Aug-2020 and a 52 week low of Rs. 75.10 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 263.50 and Rs. 237.20 respectively. The current market cap of the company is Rs. 1798.87 crore.

The promoters holding in the company stood at 50.93%, while Institutions and Non-Institutions held 10.77% and 38.29% respectively.

Unichem Laboratories has received ANDA approval for its Atenolol and Chlorthalidone Tablets, USP 50 mg/25 mg and 100 mg/25 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENORETIC (atenolol and chlorthalidone) Tablets of Alvogen Malta Operations Atenolol and Chlorthalidone Tablets are indicated for the treatment of hypertension, to lower blood pressure. The product will be commercialized from the company’s Ghaziabad Plant.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Unichem Lab Share Price

557.00 13.55 (2.49%)
17-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5802.00
Cipla 1399.35
Zydus Lifesciences 1051.90
Lupin 1653.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.